GENEURO INNOVATION SAS One line pitch: GeNeuro develops biotechnology treatments for disorders associated with endogenous retrovirus expression and presenting high unmet medical needs Market Analysis:

First Page		Document Content
Date: 2014-07-25 09:30:19 Monoclonal antibodies Immunology Humanized antibody Retrovirus ERVWE1 Biology Molecular biology Endogenous retroviruses		GENEURO INNOVATION SAS One line pitch: GeNeuro develops biotechnology treatments for disorders associated with endogenous retrovirus expression and presenting high unmet medical needs Market Analysis: Add to Reading List Source URL: www.biovision.org Download Document from Source Website File Size: 182,24 KB Share Document on Facebook